Cerenome (CNSY) Non-Current Debt (2010 - 2022)
Analysis
Cerenome (CNSY) Non-Current Debt (2010 - 2022) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 591.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 882.16 Mn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 8.96 Bn |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Cerenome | 20.42 Mn | 11.83 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 3.79 Mn |
| Sep 30, 2022 | 4.11 Mn |
| Jun 30, 2022 | 4.42 Mn |
| Mar 31, 2022 | 4.72 Mn |
| Dec 31, 2021 | 5.01 Mn |
| Jun 30, 2017 | 7.77 Mn |
| Mar 31, 2017 | 9.40 Mn |
| Dec 31, 2016 | 11.01 Mn |
| Sep 30, 2016 | 12.13 Mn |
| Jun 30, 2016 | 13.66 Mn |
| Mar 31, 2016 | 15.20 Mn |
| Dec 31, 2015 | 16.68 Mn |
| Sep 30, 2015 | 14.98 Mn |
| Jun 30, 2015 | 16.18 Mn |
| Mar 31, 2015 | 15.68 Mn |
| Dec 31, 2014 | 18.04 Mn |
| Sep 30, 2014 | 20.33 Mn |
| Jun 30, 2014 | 19.50 Mn |
| Mar 31, 2014 | 21.33 Mn |
| Dec 31, 2013 | 23.10 Mn |